Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Somavert 25mg inj vials
0605010Z0BBADAD
|
Somavert | Pegvisomant | Endocrine System | No data available |
|
Somavert 30mg inj vials
0605010Z0BBAEAE
|
Somavert | Pegvisomant | Endocrine System | No data available |
|
Somnite 2.5mg/5ml oral suspension
0401010R0BFAAAA
|
Somnite | Nitrazepam | Central Nervous System | No data available |
|
Somniton 4.6mg/24hours transdermal patches
0411000E0BIAAAF
|
Somniton | Rivastigmine | Central Nervous System | No data available |
|
Somniton 9.5mg/24hours transdermal patches
0411000E0BIABAG
|
Somniton | Rivastigmine | Central Nervous System | No data available |
|
Sonata 10mg capsules
0401010W0BBABAB
|
Sonata | Zaleplon | Central Nervous System | No data available |
|
Sonata 5mg capsules
0401010W0BBAAAA
|
Sonata | Zaleplon | Central Nervous System | No data available |
|
Sondalis 1.5 liquid
090402000BBIDA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Sondalis Fibre liquid
090402000BBICA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Sondalis ISO liquid
090402000BBIEA0
|
Proprietary compound enteral nutrition | Enteral nutrition | Nutrition and Blood | No data available |
|
Sondelbay 20micrograms/80microlitres dose inj 2.4ml pf pens
0606010U0BFAAAC
|
Sondelbay | Teriparatide | Endocrine System | No data available |
|
Soni-Slo SR 20mg capsules
0206010I0BNAAAA
|
Soni-Slo | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Soni-Slo SR 40mg capsules
0206010I0BNABAB
|
Soni-Slo | Isosorbide dinitrate | Cardiovascular System | No data available |
|
Sons DHT Blocking Hair Loss shampoo
190205500BCQNA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Soothake dental gel
120304000BBCEA0
|
Proprietary compound preparation BNF 1203040 | Other mouth wash, gargle and dentifrice preparations | Ear, Nose and Oropharynx | No data available |
|
Soothake Toothache Tincture dental liquid
120304000BBCTAL
|
Proprietary compound preparation BNF 1203040 | Other mouth wash, gargle and dentifrice preparations | Ear, Nose and Oropharynx | No data available |
|
Soothelip 5% cream
1310030C0BDAAAA
|
Soothelip | Aciclovir | Skin | No data available |
|
Sootheze Six Plus 250mg/5ml oral suspension
0407010H0CQAABG
|
Sootheze | Paracetamol | Central Nervous System | No data available |
|
Sorafenib 200mg tablets
0801050AJAAAAAA
|
Sorafenib | Sorafenib | Malignant Disease and Immunosuppression | No data available |
|
Soraway Cold Sore 5% cream
1310030C0BKAAAA
|
Soraway | Aciclovir | Skin | No data available |
|
Sorbalgon dressing 10cm x 10cm
20030200086
|
Sorbalgon dressing 10cm x 10cm | Wound Management & Other Dressings | Dressings | No data available |
|
Sorbalgon T dressing 2g
20030800065
|
Sorbalgon T dressing 2g | Wound Management & Other Dressings | Dressings | No data available |
|
Sorbex dressing 10cm x 20cm
20033000388
|
Sorbex dressing 10cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
|
Sorbex dressing 20cm x 40cm
20033000189
|
Sorbex dressing 20cm x 40cm | Wound Management & Other Dressings | Dressings | No data available |
|
Sorbex with silicone layer dressing 10cm x 20cm
20033000387
|
Sorbex with silicone layer dressing 10cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.